#USA #Nutraceuticals #Santa Ana #Robinson Pharma #USP Certification

Robinson Pharma's Expansion: A Leap Forward in Nutraceutical Manufacturing

Robinson Pharma, Inc. (RPI), a leading name in the contract manufacturing of dietary supplements and nutraceuticals, recently unveiled an ambitious expansion initiative that is set to reshape its operations in Southern California. The company has made headlines by investing over $115 million in strategic property acquisitions, ultimately enhancing its production and logistical capabilities to meet increasing global demand.

Strategic Property Acquisitions

The expansion journey commenced in December 2025, when Robinson Pharma acquired a newly constructed industrial facility situated at 3130 South Fairview Street in Santa Ana for approximately $40.7 million. This 82,241-square-foot building kicked off their expansion phase, allowing RPI to boost its manufacturing process and efficiency.

Fast forward to August 2026, and the company finalized its largest real estate deal to date with the acquisition of a massive 261,000-square-foot facility at 2323 Main Street in Irvine for an impressive $75 million. This site, located in a highly desirable logistical corridor near John Wayne Airport, will serve as a strategic addition to RPI’s network, marking the company’s tenth operational site. Collectively, these properties add nearly 350,000 square feet of cutting-edge manufacturing and warehousing space, pushing Robinson Pharma’s total operational footprint in the region past the one-million-square-foot mark.

Elevating Quality Standards

In conjunction with these expansions, Robinson Pharma achieved a significant milestone by obtaining United States Pharmacopeia (USP) certification for its latest facility. This accolade speaks volumes about the company’s commitment to maintaining the highest standards of quality assurance. The certification process included rigorous audits of RPI’s manufacturing lines, raw material controls, and finished product standards, ensuring that they meet top-tier thresholds of purity and consistency.

A representative from Robinson Pharma commented on the significance of both the infrastructure expansion and the new certification: "Our massive infrastructure investment over the last eight months reflects our absolute commitment to our clients' growth and the safety of the consumers they serve. Securing the Irvine airport facility gives us the physical capacity to scale throughput across all of our core formats—including softgels, tablets, capsules, powders, and liquids. Our newly finalized USP certification further assures health brands that they can partner with us confidently."

About Robinson Pharma

Established in 1989, Robinson Pharma is recognized for its competitive pricing, extensive production capacity, and meticulous quality standards. The company specializes in a comprehensive range of dietary supplements, producing softgels, veggie softgels, tablets, capsules, powders, and liquids tailored to meet client specifications. With advanced facilities and a focus on custom formulations and packaging solutions, Robinson Pharma ranks among the largest manufacturers in the US nutraceutical sector.

As the company continues to expand its capabilities, its commitment to quality and client satisfaction remains steadfast. With significant enhancements to its infrastructure, Robinson Pharma is well-positioned to support its clients' growth while prioritizing consumer safety. To explore their expanded manufacturing capabilities and learn more about their services, visit www.robinsonpharma.com.